Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 18 % of short-term debt in 2024; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 4 to 2.5.
Financials
Financial year 2024
De Ceunynck Radiotherapy from Aartselaar, company number BE0680604062, closed financial year 2024 with a result of € -400,468 after tax. For that financial year De Ceunynck Radiotherapy recorded a gross margin of € 82,766 and equity of € -1.6 million. Compared with financial year 2023, the result moved from € -1.4 million to € -400,468. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ -1.6 million
▼ € 400,468 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -400,468
▲ 72 % less loss than in 2023
Profit after tax over the fiscal year.
€ 92,000
▲ 22% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.7 million.
People and assets in 2024
2.5
▼ 1 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 367,391
▼ 19% vs 2023
€ 147,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,304
▼ 33% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 845,859
▲ 47% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 27,907
▼ 61% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 967,875 | € 766,484 | € -155,483 | € 82,766 | ▲ € 238,249 |
| Profit after taxes | € 616,636 | € 292,881 | € -1,433,148 | € -400,468 | ▲ € 1 million |
| Equity | € -59,370 | € 233,512 | € -1,199,637 | € -1,600,105 | ▼ € 400,468 |
| Total debts | € 6,733,182 | € 2,005,750 | € 1,979,642 | € 2,235,125 | ▲ 13% |
| Cash | € 214,513 | € 736,729 | € 75,636 | € 92,000 | ▲ 22% |
| Retained profit | € -121,370 | € 171,512 | € -1,261,637 | € -1,662,105 | ▼ € 400,468 |
| Balance sheet total | € 6,673,813 | € 2,239,262 | € 780,005 | € 635,020 | ▼ 19% |
| Employees (FTE) | 1.4 | 4 | 3.5 | 2.5 | ▼ 1 |
Key figures of De Ceunynck Radiotherapy, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to De Ceunynck Radiotherapy?
What happened at De Ceunynck Radiotherapy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 400,468. filed late Source: NBB ↗
- Jozef Van Dam stepped down as director. NBB
- New establishment in Aartselaar. KBO
- Start of the company according to the CBE. KBO
In short
From € 616,636 profit in 2021 to € 400,468 loss in 2024.
Paid € 86,635 in corporate taxes since 2021.
Best year ever: 2021, with € 616,636 profit.
On average € 33,100 of value added per employee in 2024.
A new publication or filing at De Ceunynck Radiotherapy? We notify you, reason included.
Follow De Ceunynck RadiotherapyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of E & J comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
De Ceunynck RadiotherapyBehind De Ceunynck Radiotherapy are Peter Dejonge and Erik De Ceunynck. The shares are held by E & J (99%).
Directors
According to the 2024 annual accounts
Jozef Van Dam
Managing director
· until 2024
Shareholders
99%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kontichsesteenweg 36
2630 Aartselaar
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0680.604.062
- VAT number
- BE 0680.604.062
- Registered office
- Kontichsesteenweg 36, 2630 Aartselaar
- Names & denominations
- De Ceunynck Radiotherapy
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 August 2017
- Peppol
- Active · Active since 14 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van overige farmaceutische producten
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels